FO

Foresite Capital

VC
San Francisco, CAWebsite
How to approach: warm intro preferred
Stage

Pre-Seed, Seed

Check Size

$100K – $1.0M

AUM

$3.5B

Portfolio

9+ companies

Team

10 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

Focuses on transformative life sciences technologies, with a strong interest in biotech tools and platforms that enable next-generation research and development.

Meet the Team

DR

Dennis Ryan

Chief Financial Officer

JT

Jim Tananbaum

CEO

MC

Marvin Correa

Director

HT

Hadi Tabbaa

Managing Director

MR

Michael Rome

Managing Director

AS

Amelia Stoj

Chief Compliance Officer

LB

Luke Bagaason

Director

JR

Jonathan Robbins

Director

KK

Kevin Kelly

Head Trader

VP

Vijay Pande

General Partner

Biotech
Life Sciences
DeepTech

Industry Focus

Invests In

Other
Healthcare
Deep Tech

Portfolio Companies (9)

Other

AR

Arzeda

Biotech Tools
IN

Inscripta

Life Sciences
XI

XinThera

"Discovered via firm_website (high confidence)"

HE

Health Verity

"Discovered via firm_website (high confidence)"

EI

Eikon Therapeutics

"Discovered via firm_website (high confidence)"

10

10x Genomics

"Discovered via firm_website (high confidence)"

TH

Theseus Pharmaceuticals

"Discovered via firm_website (high confidence)"

PA

Pardes Biosciences

"Discovered via firm_website (high confidence)"

XA

Xaira Therapeutics

"Discovered via firm_website (high confidence)"

Browse More Investors

Frequently Asked Questions

See if Foresite Capital is a match for your startup

Upload your pitch deck to see how well you match with Foresite Capital and 200+ other VC firms.